Merck receives European Commission approval for Zepatier hepatitis C drug
Merck receives European Commission approval for Zepatier hepatitis C drug
About this item
Full title
Merck receives European Commission approval for Zepatier hepatitis C drug
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2016
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-August 2, 2016-Merck receives European Commission approval for Zepatier hepatitis C drug (C)2016 M2 COMMUNICATIONS http://www.m2.com Merck & Co, a United States-based pharmaceutical company, has received approval from the European Commission for its Zepatier (elbasvir/grazoprevir) with or wit...
Alternative Titles
Full title
Merck receives European Commission approval for Zepatier hepatitis C drug
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1808007541
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1808007541
How to access this item
Log in as a Library member
